Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Res

Retrieve available abstracts of 58 articles:
HTML format
Text format



Single Articles


    November 2017
  1. ROCHA NN, de Oliveira MV, Braga CL, Guimaraes G, et al
    Ghrelin therapy improves lung and cardiovascular function in experimental emphysema.
    Respir Res. 2017;18:185.
    PubMed     Text format     Abstract available


  2. PEREZ-DE-LLANO L, Cosio BG
    Asthma-COPD overlap is not a homogeneous disorder: further supporting data.
    Respir Res. 2017;18:183.
    PubMed     Text format     Abstract available


    September 2017
  3. MENENDEZ R, Mendez R, Polverino E, Rosales-Mayor E, et al
    Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.
    Respir Res. 2017;18:176.
    PubMed     Text format     Abstract available


  4. TORAIH EA, Hussein MH, Al Ageeli E, Riad E, et al
    Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma.
    Respir Res. 2017;18:169.
    PubMed     Text format     Abstract available


    August 2017
  5. SALTER B, Pray C, Radford K, Martin JG, et al
    Regulation of human airway smooth muscle cell migration and relevance to asthma.
    Respir Res. 2017;18:156.
    PubMed     Text format     Abstract available


  6. BLAIS CM, Davis BE, Cockcroft DW
    The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
    Respir Res. 2017;18:146.
    PubMed     Text format     Abstract available


    July 2017
  7. DEMARCHE SF, Schleich FN, Paulus VA, Henket MA, et al
    Is it possible to claim or refute sputum eosinophils >/= 3% in asthmatics with sufficient accuracy using biomarkers?
    Respir Res. 2017;18:133.
    PubMed     Text format     Abstract available


    June 2017
  8. BARRY LE, Sweeney J, O'Neill C, Price D, et al
    The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis.
    Respir Res. 2017;18:129.
    PubMed     Text format     Abstract available


    May 2017
  9. WEBLEY WC, Hahn DL
    Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides.
    Respir Res. 2017;18:98.
    PubMed     Text format     Abstract available


  10. MALMSTROM K, Lohi J, Sajantila A, Jahnsen FL, et al
    Immunohistology and remodeling in fatal pediatric and adolescent asthma.
    Respir Res. 2017;18:94.
    PubMed     Text format     Abstract available


  11. CEELEN JJM, Schols AMWJ, van Hoof SJ, de Theije CC, et al
    Differential regulation of muscle protein turnover in response to emphysema and acute pulmonary inflammation.
    Respir Res. 2017;18:75.
    PubMed     Text format     Abstract available


    April 2017
  12. KOLSUM U, Ravi A, Hitchen P, Maddi S, et al
    Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma.
    Respir Res. 2017;18:73.
    PubMed     Text format     Abstract available


  13. JUNG KH, Torrone D, Lovinsky-Desir S, Perzanowski M, et al
    Short-term exposure to PM2.5 and vanadium and changes in asthma gene DNA methylation and lung function decrements among urban children.
    Respir Res. 2017;18:63.
    PubMed     Text format     Abstract available


  14. CRUICKSHANK-QUINN C, Armstrong M, Powell R, Gomez J, et al
    Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate.
    Respir Res. 2017;18:57.
    PubMed     Text format     Abstract available


  15. BAKER K, Raemdonck K, Snelgrove RJ, Belvisi MG, et al
    Characterisation of a murine model of the late asthmatic response.
    Respir Res. 2017;18:55.
    PubMed     Text format     Abstract available


    March 2017
  16. NATARAJAN S, Free RC, Bradding P, McGarvey L, et al
    The relationship between the Leicester cough questionnaire, eosinophilic airway inflammation and asthma patient related outcomes in severe adult asthma.
    Respir Res. 2017;18:44.
    PubMed     Text format     Abstract available


    February 2017
  17. SEYS SF, Scheers H, Van den Brande P, Marijsse G, et al
    Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients.
    Respir Res. 2017;18:39.
    PubMed     Text format     Abstract available


  18. BOULAY ME, Henry C, Bosse Y, Boulet LP, et al
    Acute effects of nicotine-free and flavour-free electronic cigarette use on lung functions in healthy and asthmatic individuals.
    Respir Res. 2017;18:33.
    PubMed     Text format     Abstract available


    January 2017
  19. MAKIKYRO EM, Jaakkola MS, Jaakkola JJ
    Subtypes of asthma based on asthma control and severity: a latent class analysis.
    Respir Res. 2017;18:24.
    PubMed     Text format     Abstract available


  20. FUJII U, Miyahara N, Taniguchi A, Oda N, et al
    Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma.
    Respir Res. 2017;18:23.
    PubMed     Text format     Abstract available


  21. BIHLET AR, Karsdal MA, Sand JM, Leeming DJ, et al
    Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.
    Respir Res. 2017;18:22.
    PubMed     Text format     Abstract available


  22. GREEN CE, Turner AM
    The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD).
    Respir Res. 2017;18:20.
    PubMed     Text format     Abstract available


  23. TAYEL SI, El-Hefnway SM, Abd El Gayed EM, Abdelaal GA, et al
    Association of stem cell factor gene expression with severity and atopic state in patients with bronchial asthma.
    Respir Res. 2017;18:21.
    PubMed     Text format     Abstract available


  24. AUGUSTO LS, Silva GC, Pinho JF, Aires RD, et al
    Vascular function in asthmatic children and adolescents.
    Respir Res. 2017;18:17.
    PubMed     Text format     Abstract available


  25. O'NEILL B, McDonough SM, Wilson JJ, Bradbury I, et al
    Comparing accelerometer, pedometer and a questionnaire for measuring physical activity in bronchiectasis: a validity and feasibility study?
    Respir Res. 2017;18:16.
    PubMed     Text format     Abstract available


  26. KIM SH, Pei QM, Jiang P, Yang M, et al
    Effect of active vitamin D3 on VEGF-induced ADAM33 expression and proliferation in human airway smooth muscle cells: implications for asthma treatment.
    Respir Res. 2017;18:7.
    PubMed     Text format     Abstract available


    December 2016
  27. LOZA MJ, Djukanovic R, Chung KF, Horowitz D, et al
    Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study.
    Respir Res. 2016;17:165.
    PubMed     Text format     Abstract available


  28. SULLIVAN A, Hunt E, MacSharry J, Murphy DM, et al
    'The Microbiome and the Pathophysiology of Asthma'.
    Respir Res. 2016;17:163.
    PubMed     Text format     Abstract available


    November 2016
  29. O'BYRNE PM, Jacques L, Goldfrad C, Kwon N, et al
    Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.
    Respir Res. 2016;17:157.
    PubMed     Text format     Abstract available


  30. KRAEMER R, Smith HJ, Sigrist T, Giger G, et al
    Diagnostic accuracy of methacholine challenge tests assessing airway hyperreactivity in asthmatic patients - a multifunctional approach.
    Respir Res. 2016;17:154.
    PubMed     Text format     Abstract available


  31. WANG M, Gao P, Wu X, Chen Y, et al
    Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma.
    Respir Res. 2016;17:153.
    PubMed     Text format     Abstract available


  32. FRANZEN S, Janson C, Larsson K, Petzold M, et al
    Evaluation of the use of Swedish integrated electronic health records and register health care data as support clinical trials in severe asthma: the PACEHR study.
    Respir Res. 2016;17:152.
    PubMed     Text format     Abstract available


  33. TERASHITA T, Kobayashi K, Nagano T, Kawa Y, et al
    Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells.
    Respir Res. 2016;17:146.
    PubMed     Text format     Abstract available


    October 2016
  34. TAILLE C, Grootenboer-Mignot S, Estellat C, Roy C, et al
    Perip7lakin is a target for autoimmunity in asthma.
    Respir Res. 2016;17:126.
    PubMed     Text format     Abstract available


  35. SOUTHWORTH T, Plumb J, Gupta V, Pearson J, et al
    Anti-inflammatory potential of PI3Kdelta and JAK inhibitors in asthma patients.
    Respir Res. 2016;17:124.
    PubMed     Text format     Abstract available


    April 2016
  36. HOONHORST SJ, Lo Tam Loi AT, Pouwels SD, Faiz A, et al
    Advanced glycation endproducts and their receptor in different body compartments in COPD.
    Respir Res. 2016;17:46.
    PubMed     Text format     Abstract available


  37. MARTIN AL, Marvel J, Fahrbach K, Cadarette SM, et al
    The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis.
    Respir Res. 2016;17:40.
    PubMed     Text format     Abstract available


  38. HIMES BE, Weitzman ER
    Innovations in health information technologies for chronic pulmonary diseases.
    Respir Res. 2016;17:38.
    PubMed     Text format     Abstract available


  39. HADEBE S, Kirstein F, Fierens K, Redelinghuys P, et al
    beta-Glucan exacerbates allergic airway responses to house dust mite allergen.
    Respir Res. 2016;17:35.
    PubMed     Text format     Abstract available


    March 2016
  40. HAMPSON JA, Stockley RA, Turner AM
    Free light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPD.
    Respir Res. 2016;17:34.
    PubMed     Text format     Abstract available


  41. KOBAYASHI Y, Ito K, Kanda A, Tomoda K, et al
    Protein tyrosine phosphatase PTP-RR regulates corticosteroid sensitivity.
    Respir Res. 2016;17:30.
    PubMed     Text format     Abstract available


  42. LAI T, Wu D, Chen M, Cao C, et al
    YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling.
    Respir Res. 2016;17:31.
    PubMed     Text format     Abstract available


  43. CALVERLEY PM, Rennard SI, Clerisme-Beaty E, Metzdorf N, et al
    Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD.
    Respir Res. 2016;17:27.
    PubMed     Text format     Abstract available


  44. FILEP A, Fodor GH, Kun-Szabo F, Tiszlavicz L, et al
    Exposure to urban PM1 in rats: development of bronchial inflammation and airway hyperresponsiveness.
    Respir Res. 2016;17:26.
    PubMed     Text format     Abstract available


    February 2016
  45. SOHAL SS
    Endothelial to mesenchymal transition (EndMT): an active process in Chronic Obstructive Pulmonary Disease (COPD)?
    Respir Res. 2016;17:20.
    PubMed     Text format     Abstract available


  46. LUO J, Wang K, Liu D, Liang BM, et al
    Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis.
    Respir Res. 2016;17:18.
    PubMed     Text format     Abstract available


    January 2016
  47. GIANNAKAKI S, Politi L, Antonogiannaki EM, Spanakis N, et al
    Absence of human rhinovirus and respiratory syncytial virus from bronchoalveolar lavage and bronchial biopsies of selected patients with stable chronic obstructive pulmonary disease.
    Respir Res. 2016;17:11.
    PubMed     Text format     Abstract available


  48. GRUNDY S, Plumb J, Kaur M, Ray D, et al
    Additive anti-inflammatory effects of corticosteroids and phosphodiesterase-4 inhibitors in COPD CD8 cells.
    Respir Res. 2016;17:9.
    PubMed     Text format     Abstract available


  49. ABE K, Sugiura H, Hashimoto Y, Ichikawa T, et al
    Possible role of Kruppel-like factor 5 in the remodeling of small airways and pulmonary vessels in chronic obstructive pulmonary disease.
    Respir Res. 2016;17:7.
    PubMed     Text format     Abstract available


  50. SINGH JA, Yu S
    Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).
    Respir Res. 2016;17:1.
    PubMed     Text format     Abstract available


  51. BRAIDO F, Brusselle G, Guastalla D, Ingrassia E, et al
    Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
    Respir Res. 2016;17:51.
    PubMed     Text format     Abstract available


  52. BAKER K, Raemdonck K, Dekkak B, Snelgrove RJ, et al
    Role of the ion channel, transient receptor potential cation channel subfamily V member 1 (TRPV1), in allergic asthma.
    Respir Res. 2016;17:67.
    PubMed     Text format     Abstract available


  53. MEBRATU YA, Smith KR, Agga GE, Tesfaigzi Y, et al
    Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses.
    Respir Res. 2016;17:75.
    PubMed     Text format     Abstract available


  54. NASSER S
    An imperfect "PAST" Lessons learned from the National Review of Asthma Deaths (NRAD) UK.
    Respir Res. 2016;17:87.
    PubMed     Text format     Abstract available


  55. OSTRIDGE K, Williams N, Kim V, Harden S, et al
    Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases.
    Respir Res. 2016;17:92.
    PubMed     Text format     Abstract available


  56. EHTESHAMI-AFSHAR S, FitzGerald JM, Carlsten C, Tavakoli H, et al
    The impact of comorbidities on productivity loss in asthma patients.
    Respir Res. 2016;17:106.
    PubMed     Text format     Abstract available


  57. XU D, Wang Y, Chen Z, Li S, et al
    Prevalence and risk factors for asthma among children aged 0-14 years in Hangzhou: a cross-sectional survey.
    Respir Res. 2016;17:122.
    PubMed     Text format     Abstract available


  58. MOHEIMANI F, Hsu AC, Reid AT, Williams T, et al
    The genetic and epigenetic landscapes of the epithelium in asthma.
    Respir Res. 2016;17:119.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: